# A Safety Study to Investigate the Skin Sensitization Potential of MFC51123

> **NCT02192203** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 227 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Diclofenac + Menthol Gel
- **DRUG:** Diclofenac Only Gel
- **DRUG:** Menthol Only Gel
- **DRUG:** Placebo Only Gel

## Key facts

- **NCT ID:** NCT02192203
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-01
- **Primary completion:** 2014-07-15
- **Final completion:** 2014-07-15
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2017-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192203, "A Safety Study to Investigate the Skin Sensitization Potential of MFC51123". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02192203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*